StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.06−0.53 (-4.21%)

Close on Nov 17, 2026Market cap $846.23MP/E 301.5Yield –

Pharming pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Pharming's pe ratio was 335.0× on Nov 11, 2026, against 60.8× a year earlier. Over the last 4 years it ranged from 14.6× to 416.0×, with a median of 53.1×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026335.0×+274.7
2024Feb 29, 202460.3×+0.1
2023Dec 29, 202360.2×+12.2
2022Dec 30, 202248.0×+31.7
2021Dec 31, 202116.3×−9.1
2020Dec 31, 202025.3×–

More Pharming figures

See a number that looks wrong?